0.444
price up icon2.07%   0.009
pre-market  Pre-market:  .48   0.036   +8.11%
loading
Immunoprecise Antibodies Ltd stock is traded at $0.444, with a volume of 734.17K. It is up +2.07% in the last 24 hours and up +4.91% over the past month. ImmunoPrecise Antibodies Ltd is a techbio company that leverages multi-omics modeling and complex artificial intelligence through a series of proprietary and patented technologies. The Company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies and are known for solving very complex industry challenges. IPA has several subsidiaries in North America and Europe.
See More
Previous Close:
$0.435
Open:
$0.44
24h Volume:
734.17K
Relative Volume:
0.10
Market Cap:
$19.54M
Revenue:
$16.77M
Net Income/Loss:
$-11.87M
P/E Ratio:
-0.9363
EPS:
-0.4742
Net Cash Flow:
$-5.90M
1W Performance:
+3.98%
1M Performance:
+4.91%
6M Performance:
-17.09%
1Y Performance:
-63.61%
1-Day Range:
Value
$0.4255
$0.469
1-Week Range:
Value
$0.40
$0.469
52-Week Range:
Value
$0.30
$1.39

Immunoprecise Antibodies Ltd Stock (IPA) Company Profile

Name
Name
Immunoprecise Antibodies Ltd
Name
Phone
-
Name
Address
-
Name
Employee
101
Name
Twitter
Name
Next Earnings Date
2024-09-16
Name
Latest SEC Filings
Name
IPA's Discussions on Twitter

Compare IPA with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
IPA
Immunoprecise Antibodies Ltd
0.444 19.54M 16.77M -11.87M -5.90M -0.4742
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
492.42 124.91B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
587.85 60.05B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
594.65 35.88B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
241.97 29.83B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
249.13 24.58B 3.81B -644.79M -669.77M -6.24

Immunoprecise Antibodies Ltd Stock (IPA) Upgrades & Downgrades

Date Action Analyst Rating Change
Dec-02-22 Initiated H.C. Wainwright Buy
Oct-25-21 Initiated The Benchmark Company Buy

Immunoprecise Antibodies Ltd Stock (IPA) Latest News

pulisher
Apr 23, 2025

What is going on with ImmunoPrecise Antibodies Ltd? Sentiment Analysis - uspostnews.com

Apr 23, 2025
pulisher
Apr 22, 2025

Will ImmunoPrecise Antibodies (NASDAQ:IPA) Spend Its Cash Wisely? - simplywall.st

Apr 22, 2025
pulisher
Apr 14, 2025

H.C. Wainwright sets $50 target for ImmunoPrecise stock - Investing.com Australia

Apr 14, 2025
pulisher
Apr 14, 2025

H.C. Wainwright sets $50 target for ImmunoPrecise stock By Investing.com - Investing.com South Africa

Apr 14, 2025
pulisher
Apr 14, 2025

ImmunoPrecise Antibodies’ (IPA) “Buy” Rating Reiterated at HC Wainwright - Defense World

Apr 14, 2025
pulisher
Apr 12, 2025

ImmunoPrecise Antibodies Highlights Alignment of Proprietary AI- - GuruFocus

Apr 12, 2025
pulisher
Apr 11, 2025

ImmunoPrecise Antibodies Highlights Alignment of Proprietary AI-Driven Platform LENSai™ with FDA's Shift to Non-Animal Testing Methods - 01net

Apr 11, 2025
pulisher
Apr 11, 2025

ImmunoPrecise Antibodies Aligns with FDA’s Move to Non-Animal Testing - TipRanks

Apr 11, 2025
pulisher
Apr 11, 2025

ImmunoPrecise Antibodies Highlights Alignment of Proprietary AI-Driven Platform LENSaitm with FDA's Shift to Non-Animal Testing Methods - Lelezard

Apr 11, 2025
pulisher
Apr 11, 2025

AI Breakthrough: How IPA's LENSai Platform Leads FDA's Historic Shift from Animal Testing - Stock Titan

Apr 11, 2025
pulisher
Apr 10, 2025

ImmunoPrecise Antibodies Partners with RIBOPRO to Enhance Antibody Discovery - TipRanks

Apr 10, 2025
pulisher
Apr 04, 2025

HC Wainwright Has Positive Outlook of IPA FY2025 Earnings - Defense World

Apr 04, 2025
pulisher
Apr 03, 2025

ImmunoPrecise Antibodies (IPA) Upgraded to Buy: What Does It Mean for the Stock? - Yahoo Finance

Apr 03, 2025
pulisher
Apr 03, 2025

HC Wainwright Has Bearish Forecast for IPA FY2028 Earnings - Defense World

Apr 03, 2025
pulisher
Apr 02, 2025

ImmunoPrecise Antibodies’ (IPA) “Speculative Buy” Rating Reaffirmed at Benchmark - Defense World

Apr 02, 2025
pulisher
Apr 01, 2025

Benchmark maintains Speculative Buy on Immunoprecise stock By Investing.com - Investing.com Australia

Apr 01, 2025
pulisher
Apr 01, 2025

Benchmark maintains Speculative Buy on Immunoprecise stock - Investing.com

Apr 01, 2025
pulisher
Apr 01, 2025

ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Q3 2025 Earnings Call Transcript - Insider Monkey

Apr 01, 2025
pulisher
Apr 01, 2025

ImmunoPrecise Antibodies (NASDAQ:IPA) Price Target Lowered to $5.00 at HC Wainwright - Defense World

Apr 01, 2025
pulisher
Mar 31, 2025

ImmunoPrecise Antibodies Earnings Call Highlights Growth - TipRanks

Mar 31, 2025
pulisher
Mar 31, 2025

Immunoprecise stock target cut to $5 by H.C. Wainwright - Investing.com Australia

Mar 31, 2025
pulisher
Mar 30, 2025

ImmunoPrecise Antibodies Ltd. (IPA) Reports Q3 Loss, Misses Revenue Estimates - MSN

Mar 30, 2025
pulisher
Mar 29, 2025

ImmunoPrecise Antibodies Ltd (IPA) Q3 2025 Earnings Call Highlights: Strategic Partnerships and ... By GuruFocus - Investing.com Canada

Mar 29, 2025
pulisher
Mar 29, 2025

ImmunoPrecise Antibodies Ltd (IPA) Q3 2025 Earnings Call Highlights: Strategic Partnerships and ... - Yahoo

Mar 29, 2025
pulisher
Mar 29, 2025

ImmunoPrecise Antibodies Ltd (IPA) Q3 2025 Earnings Call Highlig - GuruFocus

Mar 29, 2025
pulisher
Mar 29, 2025

ImmunoPrecise Antibodies Third Quarter 2025 Earnings: CA$0.66 loss per share (vs CA$0.11 loss in 3Q 2024) - Yahoo

Mar 29, 2025
pulisher
Mar 28, 2025

ImmunoPrecise Antibodies Reports Q3 FY25 Financial Results - TipRanks

Mar 28, 2025
pulisher
Mar 28, 2025

ImmunoPrecise Antibodies (IPA) Reports Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2025 - 01net

Mar 28, 2025
pulisher
Mar 28, 2025

Immunoprecise Antibodies Ltd reports results for the quarter ended January 31Earnings Summary - TradingView

Mar 28, 2025
pulisher
Mar 28, 2025

Immunoprecise Antibodies (IPA) Reports Financial Results And Recent Business Highlights For Third Quarter Fiscal Year 2025 - MarketScreener

Mar 28, 2025
pulisher
Mar 28, 2025

IMMUNOPRECISE ANTIBODIES Earnings Results: $IPA Reports Quarterly Earnings - Nasdaq

Mar 28, 2025
pulisher
Mar 28, 2025

ImmunoPrecise Secures Game-Changing $10M Deal as AI Division Reports 132% Growth - Stock Titan

Mar 28, 2025
pulisher
Mar 27, 2025

A Look Ahead: ImmunoPrecise Antibodies's Earnings Forecast - Benzinga

Mar 27, 2025
pulisher
Mar 26, 2025

IMMUNOPRECISE ANTIBODIES Earnings Preview: Recent $IPA Insider Trading, Hedge Fund Activity, and More - Nasdaq

Mar 26, 2025
pulisher
Mar 26, 2025

Immunoprecise Antibodies Ltd expected to post a loss of 8 cents a shareEarnings Preview - TradingView

Mar 26, 2025
pulisher
Mar 22, 2025

Mason Hill Advisors buying at Ascot Resources (AOT) - The Globe and Mail

Mar 22, 2025
pulisher
Mar 21, 2025

ImmunoPrecise Antibodies (IPA) to Release Quarterly Earnings on Friday - Defense World

Mar 21, 2025
pulisher
Mar 17, 2025

ImmunoPrecise Antibodies Ltd. (IPA) Reports Q4 Loss, Lags Revenue Estimates - MSN

Mar 17, 2025
pulisher
Mar 17, 2025

ImmunoPrecise Antibodies’ (IPA) Buy Rating Reiterated at HC Wainwright - Defense World

Mar 17, 2025
pulisher
Mar 13, 2025

ImmunoPrecise partners for cancer drug advancement By Investing.com - Investing.com Australia

Mar 13, 2025
pulisher
Mar 13, 2025

What's Going On With ImmunoPrecise Stock Thursday?ImmunoPrecise Antibodies (NASDAQ:IPA) - Benzinga

Mar 13, 2025
pulisher
Mar 13, 2025

ImmunoPrecise Antibodies and a Global Biotechnology Leader Enter into a USD $8M-$10M Partnership for the Development of Novel Cancer Therapeutics. - 01Net

Mar 13, 2025
pulisher
Mar 13, 2025

Sector Update: Health Care -March 13, 2025 at 08:52 am EDT - Marketscreener.com

Mar 13, 2025
pulisher
Mar 13, 2025

ImmunoPrecise Antibodies Signs Partnership Deal to Develop Cancer Treatments -March 13, 2025 at 07:55 am EDT - Marketscreener.com

Mar 13, 2025
pulisher
Mar 13, 2025

ImmunoPrecise Antibodies Partners for $10M Cancer Therapeutics Development - TipRanks

Mar 13, 2025
pulisher
Mar 13, 2025

Positive Signs As Multiple Insiders Buy ImmunoPrecise Antibodies Stock - Yahoo Finance

Mar 13, 2025
pulisher
Mar 13, 2025

ImmunoPrecise partners for cancer drug advancement - Investing.com

Mar 13, 2025

Immunoprecise Antibodies Ltd Stock (IPA) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$20.13
price down icon 0.69%
$70.80
price down icon 0.62%
$31.69
price down icon 1.55%
$33.23
price up icon 21.50%
$114.83
price up icon 9.70%
biotechnology ONC
$249.13
price down icon 1.44%
Cap:     |  Volume (24h):